Anti-factor-VIII Inhibitors in Haemophilia

This publication has 14 references indexed in Scilit:

• Anti‐idiotypes to factor VIII antibodies and their possible role in the pathogenesis and treatment of factor VIII inhibitors
  British Journal of Haematology, 1989
• Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies.
  Proceedings of the National Academy of Sciences, 1986
• ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN
  The Lancet, 1984
• Clinical experience with polyelectrolyte-fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to factor VIII
  Blood, 1984
• Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII
  Blood, 1983
• Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.
  Journal of Clinical Investigation, 1983
• Gene deletions in patients with haemophilia B and anti-factor IX antibodies
  Nature, 1983
• The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIII
  New England Journal of Medicine, 1981
• Factor VIII Inhibitor bypassing activity: A suggested mechanism of action
  Thrombosis Research, 1981
• Inhibitor of Factor VIII in Mild Haemophilia
  British Journal of Haematology, 1969